Business · 27/07/2022
FDA Announces Final Guidance for Cancer Clinical Trial Eligibility Criteria
The FDA has released a final guidance for the industry on cancer clinical trial eligibility criteria, providing recommendations for including patients who have not received available therapy in non-curative settings.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →